| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/03/2011 | US20110027267 Fusion Proteins of Mannose Binding Lectins for Treatment of Disease |
| 02/03/2011 | US20110027264 Gamma secretase modulators for the treatment of alzheimer's disease |
| 02/03/2011 | US20110027263 Soluble interleukin-20 receptor |
| 02/03/2011 | US20110027260 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/03/2011 | US20110027259 Component of bromelain |
| 02/03/2011 | US20110027258 Modified vitamin k-dependent polypeptides |
| 02/03/2011 | US20110027257 Clottable concentrate of platelet growth factors and preparation method thereof |
| 02/03/2011 | US20110027256 Fusion proteins |
| 02/03/2011 | US20110027255 Composition and Method for Treating Papilloma Virus and Equine Sarcoids |
| 02/03/2011 | US20110027254 Compositions and methods for treating gaucher disease |
| 02/03/2011 | US20110027253 Padlock probe amplification methods |
| 02/03/2011 | US20110027251 Novel uses for 4-phenylbutyrate (4pba) and its pharmaceutically acceptable salts |
| 02/03/2011 | US20110027250 Sealants for Fetal Membrane Repair |
| 02/03/2011 | US20110027249 Fusion of Peptidoglycan Hydrolase Enzymes to a Protein Transduction Domain Allows Eradication of both Extracellular and Intracellular Gram Positive Pathogens |
| 02/03/2011 | US20110027248 Sugar Chain-Related Gene and Use Thereof |
| 02/03/2011 | US20110027247 Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme q10) |
| 02/03/2011 | US20110027241 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells |
| 02/03/2011 | US20110027237 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells |
| 02/03/2011 | US20110027229 Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients |
| 02/03/2011 | US20110027228 Uses of interferons with altered spatial structure |
| 02/03/2011 | US20110027227 Antiviral drugs for treatment of arenavirus infection |
| 02/03/2011 | US20110027226 Indolopyridines as inhibitors of the kinesin spindle protein (eg5) |
| 02/03/2011 | US20110027225 MN/CA IX and EGFR Pathway Inhibition |
| 02/03/2011 | US20110027224 Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha |
| 02/03/2011 | US20110027223 Use of electrophilic compounds for inducing platelet production or maintaining platelet function |
| 02/03/2011 | US20110027222 Vaccine for the Treatment of Osteoarthritis |
| 02/03/2011 | US20110027221 Skincare Composition Comprising HSA Fusion Protein, Preparation Method And Uses Thereof |
| 02/03/2011 | US20110027219 Treatment of Crohn's disease with laquinimod |
| 02/03/2011 | US20110027218 Tnf superfamily fusion proteins |
| 02/03/2011 | US20110027209 Compositions Containing Cyclic Peptides And Methods Of Use |
| 02/03/2011 | US20110027200 Methods to stabilize and prevent breakdown of sunscreen and other topical and oral preparations and compositions produced thereby |
| 02/03/2011 | US20110027188 Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers |
| 02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
| 02/03/2011 | US20110027182 Substance for obtaining highly effective tumor medications as well as a process |
| 02/03/2011 | US20110027177 Inhibition of angiogenesis |
| 02/03/2011 | US20110027176 Homing peptide for tumor vasculature |
| 02/03/2011 | US20110027171 Ph sensitive liposome composition |
| 02/03/2011 | DE102009034779A1 Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen Synthetic analogues of bacterial lipopeptides and their use for the therapy and prophylaxis of allergic diseases |
| 02/03/2011 | CA2769754A1 Folate-targeted diagnostics and treatment |
| 02/03/2011 | CA2769645A1 Polymer particles and uses thereof |
| 02/03/2011 | CA2769525A1 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | CA2769340A1 Prodrugs comprising an insulin linker conjugate |
| 02/03/2011 | CA2769258A1 Modified factor ix polypeptides and uses thereof |
| 02/03/2011 | CA2769229A1 Derivative of glp-1 analogue or its pharmaceutical salts and their use |
| 02/03/2011 | CA2769013A1 Motilin-like peptide compound having transmucosal absorbability imparted thereto |
| 02/03/2011 | CA2768772A1 Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients |
| 02/03/2011 | CA2768404A1 Chemical method for sexual sterilization and libido elimination in male mammals |
| 02/02/2011 | EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 02/02/2011 | EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
| 02/02/2011 | EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
| 02/02/2011 | EP2280064A2 Composition comprising vegetable peptone for promoting stem cell proliferation |
| 02/02/2011 | EP2280031A1 Cancer antigens based on products of the tumor suppressor gene WT1 |
| 02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/02/2011 | EP2280027A2 New antitumoral compounds |
| 02/02/2011 | EP2280026A2 New antitumoral compounds |
| 02/02/2011 | EP2280025A2 New antitumoral compounds |
| 02/02/2011 | EP2280023A1 Tumor-associated peptides which bind to MHC molecules |
| 02/02/2011 | EP2280021A1 Pharmaceutical formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2280020A1 Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
| 02/02/2011 | EP2280019A1 Antisense modulation of C-reactive protein expression |
| 02/02/2011 | EP2280004A1 Pharmaceutique formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2279759A2 Compounds and methods for 18F labeled agents |
| 02/02/2011 | EP2279757A2 Compounds for targeting endothelial cells |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279745A2 Adiponectin as endotoxin-neutralising agent |
| 02/02/2011 | EP2279744A2 ApoE mimetic agents |
| 02/02/2011 | EP2279743A2 ApoE mimetic agents |
| 02/02/2011 | EP2279244A2 Methods and compositions for oral administration of proteins |
| 02/02/2011 | EP2279204A1 Long-acting y2 and/or y4 receptor agonists |
| 02/02/2011 | EP2279202A1 Multimeric forms of antimicrobial peptides |
| 02/02/2011 | EP2279199A1 Peptide homing to brain tumors |
| 02/02/2011 | EP2278993A1 Method of promoting wound healing |
| 02/02/2011 | EP2278992A2 Therapy for vitiligo |
| 02/02/2011 | EP2278991A1 Use of defensins against meningitis |
| 02/02/2011 | EP2278990A2 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for treating or detecting streptococcal diseases |
| 02/02/2011 | EP2278989A2 Methods of inhibiting and treating biofilms using glycopeptide antibiotics |
| 02/02/2011 | EP2278988A2 Methods to increase permeability of corneal epithelium and destabilize stromal collagen fibril network |
| 02/02/2011 | EP2278987A2 Modulation and repletion/enhancement of the complement system for treatment of trauma |
| 02/02/2011 | EP2278984A1 Compositions and methods for enhancing fertility |
| 02/02/2011 | EP2278938A2 Thiol-vinyl and thiol-yne systems for shape memory polymers |
| 02/02/2011 | EP1940445B1 Stem cell derived paracrine factor h12 for use in reducing cell death or enhancing tissue repair |
| 02/02/2011 | EP1875247B1 Selective modulation of tumour necrosis factor receptors in therapy |
| 02/02/2011 | EP1861114B1 Compositions comprising modulators of g-protein-coupled receptor for treatment of macular degeneration |
| 02/02/2011 | EP1664092B1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 02/02/2011 | EP1635651B1 Methods for hyperthyroidism in a cat and composition comprising limited iodine |
| 02/02/2011 | EP1511471B1 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/02/2011 | EP1013763B1 Canine interleukin 18 production method |
| 02/02/2011 | CN1927388B Medicinal composition containing human interferon |
| 02/02/2011 | CN1849114B Topical preparations comprising a hydrophilic carrier and a silicone matrix |
| 02/02/2011 | CN1683551B cow fetus agent prepared by composite enzyme method |
| 02/02/2011 | CN101965398A Peptides, compositions, and uses thereof |
| 02/02/2011 | CN101965397A Transferases and Oxidoreductases, Nucleic Acids Encoding them and methods for making and using them |
| 02/02/2011 | CN101965361A Biological materials and uses thereof |
| 02/02/2011 | CN101965197A Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzeimer's disease |